Callan JMB Inc. (CJMB)
NASDAQ: CJMB · Real-Time Price · USD
1.000
-0.030 (-2.91%)
At close: May 13, 2026, 4:00 PM EDT
1.000
0.00 (0.00%)
Pre-market: May 14, 2026, 4:08 AM EDT
Callan JMB Revenue
In the year 2025, Callan JMB had annual revenue of $5.72M, down -12.80%. Callan JMB had revenue of $1.16M in the quarter ending December 31, 2025, a decrease of -14.14%.
Revenue (ttm)
$5.72M
Revenue Growth
-12.80%
P/S Ratio
0.98
Revenue / Employee
$286,159
Employees
20
Market Cap
5.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.72M | -840.23K | -12.80% |
| Dec 31, 2024 | 6.56M | -6.64M | -50.29% |
| Dec 31, 2023 | 13.20M | -9.56M | -42.01% |
| Dec 31, 2022 | 22.77M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCJMB News
- 23 days ago - Callan JMB announces The Atlas Complex in Alabama - TheFly
- 26 days ago - Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC - GlobeNewsWire
- 5 weeks ago - Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer - GlobeNewsWire
- 6 weeks ago - Callan JMB to provide oversight for JKB-122 manufacturing scale-up - TheFly
- 6 weeks ago - Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement - GlobeNewsWire
- 2 months ago - Callan JMB, Attune Biotech partner for clinical trials for lodonal - TheFly
- 4 months ago - Callan JMB Stock (CJMB) Rockets 260% on Attune Biotech Deal - TipRanks
- 4 months ago - Callan JMB signs strategic teaming agreement with Biostax Corp - TheFly